Asia Pacific Drug Testing Market Size & Outlook, 2024-2030
Asia Pacific drug testing market, 2018-2030 (US$M)
Related Markets
Asia Pacific drug testing market highlights
- The Asia Pacific drug testing market generated a revenue of USD 2,636.4 million in 2024.
- The market is expected to grow at a CAGR of 5.9% from 2025 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2024.
- Rapid Testing Devices is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2030.
Asia Pacific data book summary
| Market revenue in 2024 | USD 2,636.4 million |
| Market revenue in 2030 | USD 3,723.6 million |
| Growth rate | 5.9% (CAGR from 2024 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Rapid Testing Devices |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consumables, Instruments, Rapid Testing Devices, Services |
| Key market players worldwide | Quest Diagnostics Inc, Abbott Laboratories, QuidelOrtho Corp, Roche Holding AG ADR, Thermo Fisher Scientific Inc, Siemens Healthineers AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Labcorp Holdings Inc, Clinical Reference Laboratory, Cordant Health Solutions, Legacy Medical, Draegerwerk AG & Co KGaA, Omega Laboratories |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 18.9% of the global drug testing market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,723.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Drug Testing Market Scope
Drug Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific drug testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug testing market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 34.63% in 2024. Horizon Databook has segmented the Asia Pacific drug testing market based on consumables, instruments, rapid testing devices, services covering the revenue growth of each sub-segment from 2018 to 2030.
Several key trends are reshaping the landscape of the drug testing market in Asia Pacific. One prominent trend is the increasing focus on preventing consumption of illicit drug consumption. Healthcare providers as well as government authorities in Asia Pacific
Recognize the importance of spreading awareness about harmful effects of illicit drugs. Moreover, there is a growing emphasis on innovation of new testing technologies and growing investments for product development.
Such activities are expected to offer favorable opportunity for market growth in Asia Pacific. In March 2023, Singapore Ministry of Home Affairs (MHA) announced a new plan to deploy new saliva test kit for detection of drugs at roadblocks and checkpoints.
Reasons to subscribe to Asia Pacific drug testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific drug testing market databook
-
Our clientele includes a mix of drug testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific drug testing market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific drug testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific drug testing market size, by country, 2018-2030 (US$M)
Asia Pacific Drug Testing Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
